Osmotic Pump Coating Membrane Prevents Precipitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current controlled-release drug delivery systems fail to provide a long-term and stable plasma profile for active pharmaceutical ingredients, and cellulose acetate often precipitates during the coating membrane process, leading to uneven coating and unstable drug release.
Innovation Solution
A pharmaceutical composition comprising a tablet core with a drug pull-layer and a coating membrane made of cellulose acetate and Copovidone, where the weight ratio of cellulose acetate to Copovidone is 50-90% to 10-50%, respectively, to form a semi-permeable osmotic pump system that allows controlled release of levodopa and carbidopa through osmotic pressure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional extended release dosages are used for APIs with absorption window limited at upper gastrointestinal tract, then release duration is extended, but bioavailability is compromised and therapeutic coverage is not achieved
Solution Approach 1:
The invention changes the physical state of the dosage form by creating an expandable matrix that transforms from a compact form to an expanded gel-like structure in the gastrointestinal tract. This parameter change allows the dosage form to remain in the upper GI tract longer while controlling drug release, thereby maintaining bioavailability while extending release duration
Solution Approach 2:
The dosage form incorporates dynamic properties through its ability to expand and swell in response to gastrointestinal fluids. This dynamic transformation allows the system to adapt to the physiological environment, prolonging residence time in the absorption window while maintaining controlled release characteristics
2Duration of action of moving object
If technologies such as expansion, swelling, floating, raft formation, sinking and mucosal adhesion are used to extend retention time in the stomach, then residence time is prolonged, but success is very limited especially when administered at fasting state
Solution Approach 1:
The invention uses a composite material system combining hydrophilic polymers (such as hydroxypropyl cellulose, carboxymethyl cellulose, or polyethylene oxide) with the API and excipients. This composite structure provides both expansion capability for prolonged retention and controlled release properties, achieving reliable effectiveness across different feeding states
Solution Approach 2:
The expandable matrix forms a porous structure upon expansion, allowing controlled diffusion of the API while maintaining the integrity of the dosage form. The porous network enables sustained release of the drug over extended periods while the expanded structure resists gastric emptying
3Reliability
If cellulose acetate is used in the coating membrane process, then semi-permeable properties are achieved, but precipitation occurs leading to uneven coating and unstable drug release
Solution Approach 1:
The invention introduces water-soluble polymers (such as polyethylene glycol or Povidone) as intermediary substances in the coating membrane formulation. These intermediaries act as solvents and binding agents that prevent cellulose acetate precipitation during the coating process, ensuring uniform coating distribution and stable drug release characteristics
Solution Approach 2:
The invention modifies the coating process parameters by controlling the concentration ratios of cellulose acetate to water-soluble polymers, and adjusting the solvent composition and application conditions. These parameter changes prevent precipitation and ensure homogeneous coating formation with consistent semi-permeable properties
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves a stable and prolonged release of levodopa and carbidopa, maintaining a consistent plasma profile and preventing cellulose acetate precipitation, thereby enhancing bioavailability and reducing mechanical defects in the coating membrane.
Implementation Method 1
a coating membrane made of cellulose acetate and Copovidone... to form a semi-permeable osmotic pump system that allows controlled release of levodopa and carbidopa through osmotic pressure
Data Source
AI summary
Disclosed are a pharmaceutical composition, an osmotic pump controlled-release drug delivery system comprising the pharmaceutical composition and a preparation method therefor. The pharmaceutical composition comprises a tablet core and a coating film. The tablet core comprises a drug-pulling layer, and the coating film comprises 50-90 wt % of cellulose acetate and 10-50 wt % of Copovidone. The Copovidone can be obtained by means of the polymerization of vinyl pyrrolidone and vinyl acetate in a molar ratio of 40:60-80:20.